Life Science Equity Crowdfunding Site, Capital Cell, Makes Short List for Prestigious UK Business Angels Association’Best International Growth Business’ Award

The UKBAA’s Black-Tie Investment Awards 2017 Dinner will take place on July 6th, at the Dorchester Hotel, London, with over 300 leading innovators and investors assembled to celebrate

By Robert Hoskins, Crowdfunding PR

London, United Kingdom – Capital Cell, Europe’s first equity crowdfunding platform specialized in life science, has been shortlisted for the prestigious ‘Best International Growth Business‘ award at the UK Business Angels Association Investment Awards 2017.

Life Science Equity Crowdfunding Site, Capital Cell, Makes Short List for Prestigious UK Business Angels Association Best International Growth Business Award

Capital Cell is Europe’s first equity crowdfunding platform specialized in life science. Capital Cell opens life science investment to everyone by sourcing the most innovative early-stage life science companies, and presenting them on a regulated online investment platform. In recognition of their contribution to the European life science ecosystem, the company has now been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017.

“We are absolutely thrilled that Capital Cell has been recognized so early on in it’s expansion into the UK,” says Laura Ferguson, UK Director. “The reception to our arrival has been overwhelmingly positive from players throughout the life science ecosystem, including specialized investors such as Angels in MedCity, with whom we are collaborating closely, as well as the NHS innovation, science parks and startup incubators. It’s wonderful to have that traction formally recognized.”

“Capital Cell has proven itself as a platform for early stage investment in a very challenging environment,” Chairman Ian Tomlinson added. “We are extremely excited about scaling up in the UK, which is a global leader not only in life science innovation but also in equity crowdfunding. As an investment area, life science has the potential for both huge social impact and significant financial returns and the companies listed on Capital Cell are all trying to solve a major unmet medical need. By opening up these investment opportunities to more people we hope to be able to help the UK remain at the cutting edge of life science commercialization.”

Capital Cell has been trading in Spain for just over two years, and has successfully closed 14 life science crowdfunding campaigns, including the country’s largest life science crowdfunding campaign of over €1.2M, for a potential therapeutic cure for MS.

Scaling-up from this Spanish platform, Capital Cell UK has just launched at www.capitalcell.co.uk, with a range of companies solving unmet needs from malaria control to female fertility enhancement and autoimmune disease.

The UKBAA black-tie awards dinner will take place on July 6th, at the Dorchester Hotel, London, with 300 leading innovators and investors assembled to celebrate the best of UK business.

# # #

Robert Hoskins
(512) 627-6622
@Crowdfunding_PR

---

Mr. Robert Hoskins is a seasoned marketing veteran with a proven track record of helping entrepreneurs, startups, small businesses as well as Fortune 500 corporations launch successful marketing communications campaigns to gain market traction for a wide variety of products and services.

On a regular basis, Mr. Hoskins consults with crowdfunding campaign managers as well as crowdfunding sites, portals and platforms to deliver successful crowdfunding marketing campaigns.

Google search “Robert Hoskins Crowdfunding” to see why Mr. Hoskins runs one of the industry’s foremost crowdfunding PR, social media and marketing agencies that has amassed a huge social media following and is dedicated to supporting a wide variety of donation, rewards and equity crowdfunding campaigns.